Materialise and Stratasys align 3D printing technologies to aid the production of patient-specific anatomical models

Stratasys and Materialise are pooling together their PolyJet technology and FDA-cleared Mimics inPrint software to better enable medical professionals to leverage 3D printing for anatomical models.
The two companies, two of the oldest providers of 3D printing products, unveiled their latest partnership at RSNA 2018, which is taking place between November 25 – November 30 in Chicago, IL. By working together, Stratasys and Materialise are hoping to deliver a versatile method of 3D printing patient-specific medical models at the point of care, helping doctors to diagnose and treat patients to the best of their ability.
The validation of PolyJet technology means the use of Stratasys J750, J735 and Objet30 Prime multi-material and multi-color systems are now approved by Materialise, its Mimics inPrint platform said to have been implemented by 16 of the top 20 U.S. hospitals (per U.S. News & World Report rankings).